Laboratoire Cevidra

keyboard_backspaceBack to Home

Contact

location_on

45 BOULEVARD MARCEL PAGNOL
06130 GRASSE
France

public

https://www.cevidra.com

Loïc FIEVET
Head Of Business Development
mail

l.fievet@cevidra.com

call

0785668501

About us

Since 2007, Cevidra has been a trusted French B2B partner for biotech and pharmaceutical companies, specializing in the commercialization of innovative medicines. Cevidra is a GDP/GMP-certified pharmaceutical company, providing flexible, one-stop solutions starting as early as the end of Phase 2, working alongside clinical development. Cevidra acts as Exploitant and Distributor for the French territory, while also facilitating access to other markets.

Business offer

Cevidra's comprehensive services include:

  • Exploitant Responsibilities
  • Regulatory submission support
  • Early access programs, including data collection
  • Market access strategy (Price & Reimbursement)
  • GMP batch release and secondary packaging
  • GDP-compliant distribution
  • Hospital relations and public tender strategies
  • Targeted product promotion

Activities

    Categories

    • Therapeutic Product
    • Service

    Therapeutic applications

    • Cardiology
    • Genetic Diseases
    • Oncology
    • Nervous Central System
    • Hematology
    • Infectiology
    • Immunology
    • Ophthalmology
    • Inflammation
    • Other

    Expertises

    Directory of Antibodies, Recombinant proteins and others
    • Bioproduction
    • GMP compliance
    • Batch release
    • Storage matter
    • Instruction
    • Logistic
    • Clinical trials
    • Phase II
    • Phase III
    • Phase IV
    • Regulatory filing
    • Regulatory Filing
    • Post-market surveillance
    • Post-Market Surveillance
    Cell Therapy Directory
    • Cell origin
    • Single donor
    • Tissue acquisition
    • Bioproduction engineering
    • Delivery
    • Transport
    • Supply chain logistics
    • Tracking process
    • Monitoring logistics
    Gene and CAR-T cell therapy Directory
    • Cell procurement
    • Autologous
    • Bioproduction/CMC/Analytical Quality Assessment, Quality Control
    • Supply chain logistics
    • Tracking process
    • Monitoring logistics
    Prophylactic Vaccines Directory
    • CMC
    • GMP compliance
    • Clinical trials
    • Phase II (human challenge trials)
    • Phase III (large population pending pathogen prevalence)
    • Immune monitoring
    • Data management
    • Vaccine shipment and distribution
    • Storage matter
    • Labelling
    • Packaging for shipping
    • Instruction Label
    • Digitalization of bar code
    • Cold chain logistics
    • Regulatory Filing
    • Regulatory Filing
    • New Drug Application (IND)
    • Investigational Medicinal Product (IMPT) for clinical investigations (EMA)
    • Common Technical document (CTD) section 3 (CMC) 4 (NCS) and 5 (Clinics) for submission
    • Post-market surveillance
    • Clinical Trial phase IV
    • Immune monitoring
Français English